Christoph Posch

Title: Christoph Posch: Innovator in Therapeutic Protein Purification

Introduction

Christoph Posch is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of therapeutic applications through his innovative work on fusion proteins. With a total of 2 patents, Posch has focused on improving methods for protein purification and quantification.

Latest Patents

One of Christoph Posch's latest patents is centered on the "Quantification of misfolded TNFR2:Fc." This invention is directed towards methods for determining the relative amount of wrongly disulphide bridged TNFR2:Fc in a sample. TNFR2:Fc is a fusion protein utilized in various therapeutic applications. The invention also includes a method for purifying TNFR2:Fc using the quantification method, leading to improved TNFR2:Fc compositions.

Career Highlights

Christoph Posch is currently associated with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. His work at Sandoz has allowed him to focus on the development of innovative solutions in the field of biotechnology. His expertise in protein purification has positioned him as a key player in advancing therapeutic applications.

Collaborations

Throughout his career, Christoph has collaborated with esteemed colleagues such as Alfred Rupprechter and Michael Fuchs. These collaborations have further enhanced his research and development efforts in the field of therapeutic proteins.

Conclusion

Christoph Posch's contributions to the field of therapeutic protein purification highlight his innovative spirit and dedication to advancing medical science. His patents and work at Sandoz AG reflect his commitment to improving therapeutic applications for better patient outcomes.